Group 1 - The core point of the news is that Zhijiang Bio has seen a 5% increase in stock price, reaching 23.94 CNY per share, with a total market capitalization of 4.6 billion CNY [1] - Zhijiang Bio, established on April 18, 2005, specializes in the research, production, and sales of molecular diagnostic reagents and equipment, with 86.47% of its revenue coming from nucleic acid testing kits [1] - The company is located in Minhang District, Shanghai, and was listed on January 18, 2021 [1] Group 2 - Among the top circulating shareholders of Zhijiang Bio, Dazhong Fund's Dazhong Jingheng Mixed A (090019) holds 909,200 shares, unchanged from the previous period, representing 0.47% of circulating shares [2] - Dazhong Jingheng Mixed A has achieved a year-to-date return of 46.93%, ranking 1332 out of 8140 in its category [2] - The fund was established on June 15, 2012, and has a current scale of 694 million CNY, with a cumulative return of 393.36% since inception [2]
之江生物股价涨5%,大成基金旗下1只基金位居十大流通股东,持有90.92万股浮盈赚取103.65万元